{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:51Z","timestamp":1759048071346},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T00:00:00Z","timestamp":1140739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with multifocal motor neuropathy (MMN) respond to intravenous immune globulin (IVIg) and cyclophosphamide, although the benefit is not sustained. High\u2010dose cyclophosphamide can induce a remission in patients with autoimmune diseases, including chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). We describe a patient with refractory MMN who improved with high\u2010dose cyclophosphamide (50 mg\/kg for 4 days) without stem cell rescue. Following treatment she discontinued IVIg. At a 6\u2010month examination, her strength had improved and she had regained the ability to write. High\u2010dose cyclophosphamide may be a successful treatment for patients with MMN refractory to other therapies. Muscle Nerve, 2006<\/jats:p>","DOI":"10.1002\/mus.20524","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T00:47:42Z","timestamp":1140828462000},"page":"246-250","source":"Crossref","is-referenced-by-count":23,"title":["High\u2010dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy"],"prefix":"10.1002","volume":"34","author":[{"suffix":"III","given":"Thomas H.","family":"Brannagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Alaedini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,2,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20024"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.12.1856"},{"key":"e_1_2_6_5_2","first-page":"A204","article-title":"Immunoablative high\u2010dose cyclophosphamide without stem\u2010cell rescue for refractory chronic inflammatory demyelinating polyneuropathy (CIDP) and other immune\u2010mediated neuropathies","volume":"56","author":"Brannagan TH","year":"2001","journal-title":"Neurology"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00007"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-7-200110020-00006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1480"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330303"},{"key":"e_1_2_6_10_2","first-page":"95","article-title":"Relapsing chronic low\u2010dose corticosteroid\u2010responsive multifocal motor neuropathy with conduction block","volume":"37","author":"de Carvalho M","year":"1997","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.7.778"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10400"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.5.967"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1256"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300312"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.019232"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2005.10104.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu229oa"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(00)00191-7"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.10.2742.bloodjournal85102742"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.506"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20076"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.314"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.118"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2003.10.045"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.2.197"},{"key":"e_1_2_6_27_2","first-page":"3027","article-title":"Long\u2010term follow up of multifocal motor neuropathy patients treated with intravenous immunoglobulins and oral cyclophosphamide","volume":"46","author":"Meucci N","year":"1996","journal-title":"Neurology"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.6.727"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0131-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880110203"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240113"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.4.485"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10752"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05076.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380815"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000098996.02934.86"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000145706.04340.25"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20173"},{"key":"e_1_2_6_39_2","first-page":"326","article-title":"Fludarabine for IgM antibody\u2010mediated neuropathies","volume":"36","author":"Sherman WH","year":"1994","journal-title":"Ann Neurol"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.33333"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000110185.23464.A1"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg019"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.4.1135"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.20524","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.20524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:41:56Z","timestamp":1697107316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.20524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,24]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1002\/mus.20524"],"URL":"https:\/\/doi.org\/10.1002\/mus.20524","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"value":"0148-639X","type":"print"},{"value":"1097-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,24]]}}}